Conservative Management of Patients with End-Stage Renal Disease #408

Murtagh FE , Addington-Hall J , Edmonds P , et al.: Symptoms in the month before death for stage 5 chronic kidney disease patients managed without dialysis. J Pain Symptom Manage, 2010; 40:342–352.

Chin-Yee N , Taylor J , Rourke K , et al.: Red blood cell transfusion in adult palliative care: A systematic review. Transfusion, 2017; 58:233–241.

Cheng HWB , Chan KY , Lau HT , et al.: Use of erythropoietin-stimulating agents (ESA) in patients with end-stage renal failure decided to forego dialysis: Palliative perspective. Am J Hosp Palliat Care, 2017; 34:380–384.

Jhamb M , Weisbord SD , Steel JL , Unruh M : Fatigue in patients receiving maintenance dialysis: A review of definitions, measures, and contributing factors. Am J Kidney Dis, 2008; 52:353–365.

Rayner H , Larkina M , Wang M : International comparisons of prevalence, awareness, and treatment of pruritus in people on hemodialysis. Clin J Am Soc Nephrol, 2017; 12:2000–2007.

Mathur V , Lindberg J , Germain M , et al.: A longitudinal study of uremic pruritus in hemodialysis patients. Clin J Am Soc Nephrol, 2010; 5:1410–1419.

Simonsen E , Komenda P , Lerner B , et al.: Treatment of Uremic pruritus: A systematic review. Am J Kidney Dis, 2017; 70:638–655.

Pauli-Magnus C , Klumpp S , Alscher DM , et al.: Short-term efficacy of tacrolimus ointment in severe uremic pruritus. Perit Dial Int, 2000; 20:802–803.

Gilchrest BA , Rowe JW , Brown RS , et al.: Ultraviolet phototherapy of uremic pruritus. long-term results and possible mechanism of action. Ann Intern Med, 1979; 91:17–21.

Mettang T , Kremer A : Uremic pruritus. Kidney Int, 2015; 87:685–691.

Fishbane S , Jamal A , Munera C , et al.: KALM-1 Trial Investigators. A phase 3 trial of difelikefalin in hemodialysis patients with pruritus. N Engl J Med, 2020; 382:222–232.

Davison S : Clinical pharmacology considerations in pain management in patients with advanced kidney failure. CJASN, 2019; 14:917–931.

Polizzotto MN , Bryan T , Ashby MA , Martin P : Symptomatic management of calciphylaxis: A case series and review of the literature. J Pain Symptom Manage, 2006; 32:186–190.

Peppin J , Albrecht P , Argoff C , et al.: Skin Matters: A review of topical treatments for chronic pain. Part two: Treatments and applications. Pain Ther, 2015; 4:33–50.

United Kingdom National Health Service: Topical morphine for painful skin ulcers in palliative care: A treatment guideline. East Lancashire Health Economy Medicines Management Board. Published 2009. Updated April 2016. http://www.elmmb.nhs.uk/policies-and-guidelines/palliative-care/. (Last accessed October 21, 2020).

Ribeiro M , Joel S , Zeppetella G : The bioavailability of morphine applied topically to cutaneous ulcers. J Pain Symptom Manage, 2004; 27:434–439.

Johnson MJ , Booth S : Palliative and end-of-life care for patients with chronic heart failure and chronic lung disease. Clin Med (Lond), 2010; 10:286–289.

Oh SW , Han SY : Loop diuretics in clinical practice. Electrolytes Blood Press, 2015; 13:17–21.

O'Connor N , Kumar P : Conservative management of end-stage renal disease without dialysis: A systematic review. J Pallit Med, 2012; 15:228–235.

O'Connor N , Dougherty M , Harris P , Casarett D : Survival after dialysis discontinuation and hospice enrollment for ESRD. Clin J Am Soc Neprol, 2013; 12:2117–2122.

Bhambri A , Del Rosso J : Calciphylaxis: A review. J Clin Aesthetic Derm, 2008; 1:38–41.

Shah KK , Murtagh FE , McGeechan K , et al.: Health related quality of life and well-being in people over 75 years of age with end stage kidney disease management with dialysis or comprehensive conservative care: A cross-sectional study in the UK and Australia. BMJ Open, 2019; 9:e027776.